HuLuc63

A drug used with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer was already treated with other anticancer therapies. HuLuc63 binds to a protein called CS1, which is found on myeloma cells and some types of immune cells. HuLuc63 may block CS1 and help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called elotuzumab and Empliciti.